Lutz Löning

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text

Medicine, Oncology, Pediatrics +14

Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy

Lutz Löning, Martin Zimmermann, Alfred Reiter et al. · Blood · 2000 · 266 citations

Medicine, Oncology, Pediatrics +13

Diagnostic Cerebrospinal Fluid Examination in Children With Acute Lymphoblastic Leukemia: Significance of Low Leukocyte Counts With Blasts or Traumatic Lumbar Puncture

B. Bürger, Martin Zimmermann, Georg Mann et al. · Journal of Clinical Oncology · 2003 · 262 citations

Medicine, Hematology, Oncology +13

Pegylated asparaginase (Oncaspar^TM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols

Hans‐Joachim Müller, Lutz Löning, Alexander Horn et al. · British Journal of Haematology · 2000 · 122 citations · Full text

Medicine, Oncology, Pediatrics +13

Pharmacokinetics of native <i>Escherichia coli</i> asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL‐BFM 95 reinduction treatment

Hans‐Joachim Müller, Rita Beier, Lutz Löning et al. · British Journal of Haematology · 2001 · 95 citations

Life Sciences, Immunology, Pharmacokinetics +13